IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Acadia Pharmaceuticals Inc

CUSIP: 004225909 | 1 institutional holders

Quarters

Q4 2013
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile